In the three cancer types studied, colorectal cancer, endometrial cancer, and ovarian cancer, TMB was significantly higher when the corresponding POLE ExoD driver mutation was present in conjunction with one or more additional POLE variant(s). This evidence concerns the gene POLE and ovarian carcinoma.